1 Boring Old Man » hiding uptown… [more]

about
search

wait… »

Posted on Thursday 1 December 2011

Looking at the timeline on my last post, I got confused myself. Here’s another attempt showing: DATE, CLINICAL TRIAL D1050231, FDA, AJP [article history], OTHER [presentations], MERGER [Dianippon Sumitomo Pharma & Sepracor]:

Latuda®

^DATE	^{CLINICAL TRIAL D1050231}				^FDA	^AJP	^OTHER	^MERGER
	^SPONSOR	^STATUS	^{STUDY P.I.}	^AGENCY

^02/13/08	^DSP	^Recruiting	^Sonnenberg	^Uptown				^DSP	^Sepracor
^03/18/08	^DSP	^Recruiting	^Sonnenberg	^Uptown				^DSP	^Sepracor
^10/**/09								^DSP+Sepracor
^12/06/09							^ACNP
^12/30/09					^Received
^02/22/10	^DSP	^{Not Recruiting}	^Sonnenberg	^Uptown
^03/16/10	^DSP	^Completed	^Sonnenberg	^Uptown
^04/**/10								^Sunovion
^05/22/10							^{APA, NO}
^06/01/10						^Received
^09/10/10					^Reviewed
^10/27/10					^Approved
^11/03/10						^Revised
^02/11/11	^Sunovion	^Completed	^{[all sites]}	^{All sites}
^02/15/11	^Sunovion	^Completed	^{[all sites]}	^{All sites}
^02/20/11						^Revised
^03/04/11	^Sunovion	^Completed	^{Med. Director}	^Sunovion
^03/16/11	^Sunovion	^Completed	^{Med. Director}	^Sunovion
^03/21/11						^Accepted
^09/01/11						^Published
^09/09/11	^Sunovion	^Completed	^{Med. Director}	^Sunovion

The Latuda® Clinical Trial [D1050231] was completed by the end of 2009 by the Uptown Research Institute under the direction of Dr. John Sonnenberg – ready for a presentation at the 2009 American College of Neuropsychopharmacology [ACNP] meeting and to be submitted to the FDA for approval. My guess is that Quinitiles became involved in early 2010, around the time Sunovion was formed since we know Quinitiles was part of the American Journal of Psychiatry [AJP] article, and I’m guessing that Quinitiles was involved in the American Psychiatric Association [APA] presentation in New Orleans. All of the public bru-ha-ha about Drs. Reinstein and Sonnenberg was at the end of 2009 and in early 2010.

Sorry, the comment form is closed at this time.